Neurostimulation Device Market Report

Global and Region Neurostimulation Device Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：214
  • REPORT CODE：GMM899864
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A neurostimulation device is an instrument used for neuromodulation. Neuromodulation is the process of using implantable medical devices to adjust and change nerve activity to achieve therapeutic goals. Neurostimulation device help treat neurological diseases and help deliver electrical stimulation to the patient's brain, peripheral nervous system and desired parts of the spinal cord.

    In September 2019, the FDA approved SPR Therapeutics’s Proclaim XR non-chargeable neurostimulation device. The approval helps the company expand its neurostimulation device product portfolio and ensures the company's higher market share.

    Some of the key factors driving the growth of the neurostimulation device market include the growth of the elderly population, the introduction of technologically advanced products, and the increase in the incidence of chronic diseases such as migraine and epilepsy.

    The report details the trend, potential and market size of Neurostimulation Device market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Neurostimulation Devicemarket, defines the market attractiveness level of Neurostimulation Device market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Neurostimulation Device industry, describes the types of Neurostimulation Device market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neurostimulation Device market and the development prospects and opportunities of Neurostimulation Device industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neurostimulation Device market in Chapter 13.

    By Player:

    • SPR Therapeutics

    • IntraPace Inc

    • Nevro Corp

    • LivaNova PLC

    • Boston Scientific Corporation

    • Abbott

    • Medtronic

    • NeuroPace

    • Bayer AG

    • Neuronetics Inc

    • Laborie Inc

    By Type:

    • Deep Brain Stimulation

    • Gastric Electrical Stimulation

    • Spinal Cord Stimulation

    • Vagus Nerve Stimulation

    • Other

    By End-User:

    • Epilepsy

    • Urinary Incontinence

    • Depression

    • Dystonia

    • Parkinson's Disease

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Neurostimulation Device Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Neurostimulation Device Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Neurostimulation Device Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Neurostimulation Device Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Neurostimulation Device Market Analysis and Outlook to 2022

    • 7.1 Global Neurostimulation Device Consumption (2017-2022)

    • 7.2 United States Neurostimulation Device Consumption (2017-2022)

    • 7.3 Europe Neurostimulation Device Consumption (2017-2022)

    • 7.4 China Neurostimulation Device Consumption (2017-2022)

    • 7.5 Japan Neurostimulation Device Consumption (2017-2022)

    • 7.6 India Neurostimulation Device Consumption (2017-2022)

    • 7.7 South Korea Neurostimulation Device Consumption (2017-2022)

    8 Region and Country-wise Neurostimulation Device Market Analysis and Outlook to 2028

    • 8.1 Global Neurostimulation Device Consumption Forecast (2022-2028)

    • 8.2 United States Neurostimulation Device Consumption Forecast (2022-2028)

    • 8.3 Europe Neurostimulation Device Consumption Forecast (2022-2028)

    • 8.4 China Neurostimulation Device Consumption Forecast (2022-2028)

    • 8.5 Japan Neurostimulation Device Consumption Forecast (2022-2028)

    • 8.6 India Neurostimulation Device Consumption Forecast (2022-2028)

    • 8.7 South Korea Neurostimulation Device Consumption Forecast (2022-2028)

    9 Global Neurostimulation Device Market Outlook by Types and Applications to 2022

    • 9.1 Global Neurostimulation Device Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Deep Brain Stimulation Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Gastric Electrical Stimulation Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Spinal Cord Stimulation Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Vagus Nerve Stimulation Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neurostimulation Device Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Epilepsy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Urinary Incontinence Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Depression Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Dystonia Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Parkinson's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Neurostimulation Device Market Outlook by Types and Applications to 2028

    • 10.1 Global Neurostimulation Device Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Deep Brain Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Gastric Electrical Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Spinal Cord Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Vagus Nerve Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Neurostimulation Device Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Urinary Incontinence Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Depression Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Dystonia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Neurostimulation Device Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Neurostimulation Device Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Neurostimulation Device Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Neurostimulation Device Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Neurostimulation Device Market Competitive Analysis

    • 14.1 SPR Therapeutics

      • 14.1.1 SPR Therapeutics Company Details

      • 14.1.2 SPR Therapeutics Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 SPR Therapeutics Neurostimulation Device Product and Service

    • 14.2 IntraPace Inc

      • 14.2.1 IntraPace Inc Company Details

      • 14.2.2 IntraPace Inc Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 IntraPace Inc Neurostimulation Device Product and Service

    • 14.3 Nevro Corp

      • 14.3.1 Nevro Corp Company Details

      • 14.3.2 Nevro Corp Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Nevro Corp Neurostimulation Device Product and Service

    • 14.4 LivaNova PLC

      • 14.4.1 LivaNova PLC Company Details

      • 14.4.2 LivaNova PLC Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 LivaNova PLC Neurostimulation Device Product and Service

    • 14.5 Boston Scientific Corporation

      • 14.5.1 Boston Scientific Corporation Company Details

      • 14.5.2 Boston Scientific Corporation Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Boston Scientific Corporation Neurostimulation Device Product and Service

    • 14.6 Abbott

      • 14.6.1 Abbott Company Details

      • 14.6.2 Abbott Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Abbott Neurostimulation Device Product and Service

    • 14.7 Medtronic

      • 14.7.1 Medtronic Company Details

      • 14.7.2 Medtronic Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Medtronic Neurostimulation Device Product and Service

    • 14.8 NeuroPace

      • 14.8.1 NeuroPace Company Details

      • 14.8.2 NeuroPace Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 NeuroPace Neurostimulation Device Product and Service

    • 14.9 Bayer AG

      • 14.9.1 Bayer AG Company Details

      • 14.9.2 Bayer AG Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bayer AG Neurostimulation Device Product and Service

    • 14.10 Neuronetics Inc

      • 14.10.1 Neuronetics Inc Company Details

      • 14.10.2 Neuronetics Inc Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Neuronetics Inc Neurostimulation Device Product and Service

    • 14.11 Laborie Inc

      • 14.11.1 Laborie Inc Company Details

      • 14.11.2 Laborie Inc Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Laborie Inc Neurostimulation Device Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Neurostimulation Device

    • Figure Neurostimulation Device Picture

    • Table Global Neurostimulation Device Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neurostimulation Device Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neurostimulation Device Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Neurostimulation Device Consumption by Country (2017-2022)

    • Figure United States Neurostimulation Device Consumption and Growth Rate (2017-2022)

    • Table Europe Neurostimulation Device Consumption and Growth Rate (2017-2022)

    • Figure China Neurostimulation Device Consumption and Growth Rate (2017-2022)

    • Figure Japan Neurostimulation Device Consumption and Growth Rate (2017-2022)

    • Figure India Neurostimulation Device Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neurostimulation Device Consumption and Growth Rate (2017-2022)

    • Figure Global Neurostimulation Device Consumption Forecast by Country (2022-2028)

    • Figure United States Neurostimulation Device Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neurostimulation Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Neurostimulation Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neurostimulation Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neurostimulation Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neurostimulation Device Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Deep Brain Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Gastric Electrical Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Spinal Cord Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Vagus Nerve Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure Global Urinary Incontinence Consumption and Growth Rate (2017-2022)

    • Figure Global Depression Consumption and Growth Rate (2017-2022)

    • Figure Global Dystonia Consumption and Growth Rate (2017-2022)

    • Figure Global Parkinson's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Deep Brain Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastric Electrical Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Spinal Cord Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vagus Nerve Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urinary Incontinence Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Depression Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dystonia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Neurostimulation Device Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Neurostimulation Device Export by Region (Top 5 Countries) (2017-2028)

    • Table SPR Therapeutics (Foundation Year, Company Profile and etc.)

    • Table SPR Therapeutics Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table SPR Therapeutics Neurostimulation Device Product and Service

    • Table IntraPace Inc (Foundation Year, Company Profile and etc.)

    • Table IntraPace Inc Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table IntraPace Inc Neurostimulation Device Product and Service

    • Table Nevro Corp (Foundation Year, Company Profile and etc.)

    • Table Nevro Corp Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nevro Corp Neurostimulation Device Product and Service

    • Table LivaNova PLC (Foundation Year, Company Profile and etc.)

    • Table LivaNova PLC Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table LivaNova PLC Neurostimulation Device Product and Service

    • Table Boston Scientific Corporation (Foundation Year, Company Profile and etc.)

    • Table Boston Scientific Corporation Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Corporation Neurostimulation Device Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Neurostimulation Device Product and Service

    • Table Medtronic (Foundation Year, Company Profile and etc.)

    • Table Medtronic Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Neurostimulation Device Product and Service

    • Table NeuroPace (Foundation Year, Company Profile and etc.)

    • Table NeuroPace Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table NeuroPace Neurostimulation Device Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Neurostimulation Device Product and Service

    • Table Neuronetics Inc (Foundation Year, Company Profile and etc.)

    • Table Neuronetics Inc Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neuronetics Inc Neurostimulation Device Product and Service

    • Table Laborie Inc (Foundation Year, Company Profile and etc.)

    • Table Laborie Inc Neurostimulation Device Sales, Price, Value and Gross Profit (2017-2022)

    • Table Laborie Inc Neurostimulation Device Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US